What are the common mimickers of irritable bowel syndrome and how should they be investigated?

IBS Mimickers: Common Differential Diagnoses and Investigation Strategy

Use a positive diagnostic strategy for IBS based on Rome IV criteria while simultaneously ruling out key organic mimickers through targeted testing—specifically celiac disease, inflammatory bowel disease, microscopic colitis, and infectious causes—rather than pursuing exhaustive exclusionary testing. 1, 2

Primary Organic Mimickers to Exclude

Celiac Disease

• Serologic testing for celiac disease is mandatory in all patients with IBS-like symptoms, particularly those with diarrhea-predominant features 1, 3
• This represents the single most important blood test to perform, as celiac disease presents identically to IBS-D but requires completely different management 2

Inflammatory Bowel Disease (IBD)

• Check fecal calprotectin in patients with suspected IBS and diarrhea symptoms to rule out IBD 1, 2
• Calprotectin levels >250 μg/g strongly suggest active inflammation and correlate well with endoscopic findings 4
• Patients with indeterminate levels (50-249 μg/g) have an 8% chance of developing IBD within 12 months compared to 1% in those with levels <50 μg/g 4
• Note that calprotectin can also be elevated by colorectal cancer, infectious gastroenteritis, and NSAIDs 4

Microscopic Colitis

• Colonoscopy with right- and left-sided biopsies is essential when initial testing is negative but symptoms persist, as microscopic colitis appears endoscopically normal 4
• This diagnosis is found in 7-31% of patients undergoing colonoscopy for chronic diarrhea 4

Parasitic Infections (Particularly Giardia)

• Giardia is the most common parasitic cause of IBS-like symptoms, presenting with diarrhea, bloating, and pain lasting 2-6 weeks but potentially becoming chronic 5
• Consider testing in high-risk populations: recent travel to endemic areas, consumption of untreated water, hikers, daycare exposure, and men who have sex with men 5
• Current CDC guidelines recommend testing 3 stool samples for ova and parasites, followed by molecular testing (enzyme immunoassay for Giardia antigen or PCR) if suspicion remains high 5
• An empiric trial of therapy is reasonable when pretest probability is high but testing is negative 5

Colorectal Neoplasia

• Fecal immunochemical testing (FIT) has high negative predictive value (0.99) with optimal cut-off between 7-10 μg/g for ruling out colorectal cancer in symptomatic patients 4
• Change in bowel habit alone is a poor predictor of neoplasia (only 7% of patients with altered bowel habits had colonic neoplasms), but colonoscopy is warranted when alarm features are present 4

Alarm Features Requiring Colonoscopy

Proceed directly to colonoscopy with ileoscopy and biopsies when any of the following are present 4, 2:

• Age >40-50 years (depending on regional guidelines) with new-onset symptoms
• Rectal bleeding
• Unintentional weight loss
• Nocturnal symptoms
• Family history of colorectal cancer or IBD
• Anemia or elevated inflammatory markers

Colonoscopy with ileoscopy identifies pathology in 15-20% of chronic diarrhea cases, with terminal ileal disease found in 36% of patients with normal colonoscopy 4

Emerging Biomarkers (Limited Current Role)

Anti-CdtB and anti-vinculin antibodies have been studied for "ruling in" post-infectious IBS-D 5, 4:

• These tests show reasonable specificity and high positive predictive value when positive 5
• However, sensitivity is <50%, so negative tests do not exclude IBS-D 5
• Their clinical utility remains hypothesis-generating rather than confirmatory, and they are not recommended for routine use 5

Age-Specific Diagnostic Approach

Patients Under Age 40

• A diagnosis of IBS may be made in primary care without endoscopy if typical functional bowel disorder symptoms are present, alarm features are absent, and initial blood/stool tests are negative 4
• Severe symptoms or documented objective diarrhea (not just patient-reported loose stools) warrant full evaluation regardless of age 4

Patients Over Age 40

• Lower threshold for colonoscopy due to increased colorectal cancer risk 4, 2

Essential Initial Laboratory Panel

The minimum workup should include 2, 3:

• Full blood count (to detect anemia)
• C-reactive protein (elevated in IBD, infections, malignancy)
• Celiac serology (tissue transglutaminase IgA with total IgA)
• Fecal calprotectin (for IBD screening)

Do NOT routinely test for food allergies, as this is not recommended 3

Common Pitfalls to Avoid

• Do not pursue multiplex stool PCR panels routinely in chronic diarrhea without high pretest probability, as the cost per significant organism identified is $1836 and their role remains undetermined 5
• Do not rely on flexible sigmoidoscopy alone—nearly half of neoplasms are proximal to the splenic flexure, requiring full colonoscopy 4
• Do not skip ileoscopy during colonoscopy, as 18% of non-HIV patients with diarrhea have terminal ileal pathology 4
• Do not forget digital rectal examination, which is recommended as part of the initial assessment 2